Related Experiment Video

Updated: Feb 21, 2026

Modeling Posthemorrhagic Hydrocephalus of Prematurity in Rats
04:20

Modeling Posthemorrhagic Hydrocephalus of Prematurity in Rats

Published on: March 28, 2025

637

Root causes for late presentation of severe neonatal hyperbilirubinaemia in Egypt

I Iskander1, R Gamaleldin, M Kabbani

  • 1Department of Paediatrics, University of Cairo, Cairo, Egypt. imanisk@hotmail.com

Eastern Mediterranean Health Journal = La Revue De Sante De La Mediterranee Orientale = Al-Majallah Al-Sihhiyah Li-Sharq Al-Mutawassit
|October 13, 2012
PubMed

Insights

Late presentation of severe neonatal jaundice is common, often due to a lack of discharge examinations and jaundice education. Inexpensive diagnostic tools and phototherapy are urgently needed in healthcare facilities to improve infant care.

Area of Science:

  • Neonatal Medicine
  • Pediatrics
  • Public Health

Background:

  • Severe neonatal hyperbilirubinemia (jaundice) poses significant health risks to infants.
  • Late presentation to healthcare facilities delays critical treatment for severe jaundice.
  • Understanding parental and healthcare system factors contributing to delayed diagnosis is crucial for intervention.

Purpose of the Study:

  • To investigate the reasons behind the late presentation of severe neonatal hyperbilirubinemia cases.
  • To identify gaps in healthcare practices and parental knowledge regarding neonatal jaundice management.

Main Methods:

  • A questionnaire was administered to parents of 130 infants with severe jaundice admitted to a neonatal intensive care unit at or after 6 days of age.
  • Data collected included delivery location, discharge examination practices, parental instructions, and prior medical advice sought.

Main Results:

  • Most infants (96.2%) were born in healthcare facilities, yet 79.2% lacked a discharge physical examination.
  • No parents received instructions on neonatal jaundice or had follow-up appointments scheduled.
  • Prior medical advice often involved home phototherapy (neon lamps) or breastfeeding supplementation, with limited serum bilirubin testing (25%).

Conclusions:

  • Deficiencies in discharge protocols and parental education contribute significantly to delayed diagnosis of severe neonatal jaundice.
  • There is an urgent need for accessible, affordable point-of-care diagnostic tools and phototherapy units in healthcare settings.
  • Improved healthcare facility practices and public health initiatives are essential to prevent severe outcomes of neonatal hyperbilirubinemia.

More Related Videos

A Neonatal Imaging Model of Gram-Negative Bacterial Sepsis08:46

A Neonatal Imaging Model of Gram-Negative Bacterial Sepsis

Published on: August 12, 2020

7.0K
Modeling Encephalopathy of Prematurity Using Prenatal Hypoxia-ischemia with Intra-amniotic Lipopolysaccharide in Rats07:36

Modeling Encephalopathy of Prematurity Using Prenatal Hypoxia-ischemia with Intra-amniotic Lipopolysaccharide in Rats

Published on: November 20, 2015

11.9K

Related Concept Videos

Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
350
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
346
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
269
Inborn Errors of Metabolism01:20

Inborn Errors of Metabolism

Phenylketonuria (PKU) is a protein metabolism disorder characterized by high blood levels of the amino acid phenylalanine. This results from a mutation in the gene responsible for phenylalanine hydroxylase, an enzyme that converts phenylalanine into tyrosine. When this enzyme is deficient, phenylalanine builds up in the blood, leading to symptoms such as vomiting, rashes, seizures, growth deficiency, and severe mental retardation. An early diagnosis and a diet restricting phenylalanine intake...
936
Diseases of the Liver and Gallbladder01:26

Diseases of the Liver and Gallbladder

Liver and gallbladder diseases are a significant health concern, with prominent conditions including cirrhosis, hepatitis, non-alcoholic fatty liver disease (NAFLD), and gallstones. Jaundice is a common manifestation of liver and biliary disease.
Cirrhosis is characterized by the scarring of hepatic lobules in the liver, which are replaced by fibrous tissue, affecting the liver's normal functioning. NAFLD, on the other hand, is caused by an excessive build-up of fat in the liver, not...
2.1K